51234 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 18
13:30 UTC
|
HESAY
Hermes International
|
↓ Downgrade | firm only | Outperform→ Sector Perform | |
|
Aug 18
13:30 UTC
|
GSAT
Globalstar
|
↓ Downgrade | firm only | Buy→ Hold | $90.00 |
|
Aug 18
13:30 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
↓ Downgrade | Andreas Argyrides ★★★☆☆ #1363 | Buy→ Neutral | $5.00 |
|
Aug 18
13:30 UTC
|
ATHM
Autohome
|
↓ Downgrade | firm only | Neutral→ Underperform | $19.00 |
|
Aug 18
13:30 UTC
|
STRW
Strawberry Fields REIT
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 18
13:30 UTC
|
DUOL
Duolingo
|
↑ Upgrade | Wyatt Swanson ★★☆☆☆ #2771 | Neutral→ Buy | $130.00→ $160.00+23.1% |
|
Aug 18
13:30 UTC
|
BBWI
Bath & Body Works
|
↑ Upgrade | Paul Lejuez ★★★★☆ #928 | Neutral→ Buy | $25.00 |
|
Aug 18
13:30 UTC
|
AMX
America Movil
|
↑ Upgrade | Marcelo Santos ★★★☆☆ #1195 | Neutral→ Overweight | $30.00→ $32.00+6.7% |
|
Aug 18
12:33 UTC
|
TNGX
Tango Therapeutics
|
◎ Target | Robert Burns ★★★☆☆ #1757 | Buy | $66.00→ $68.00+3.0% |
|
Aug 18
12:33 UTC
|
STEX
Biosig Technologies
|
◎ Target | John Todaro ★★☆☆☆ #2577 | Buy | $4.00 |
|
Aug 18
12:33 UTC
|
SNOW
Snowflake
|
◎ Target | Patrick Walravens ★★★★★ #143 | Market Outperform | $325.00→ $408.00+25.5% |
|
Aug 18
12:33 UTC
|
SBET
Sharplink Gaming
|
◎ Target | Joseph Vafi ★★☆☆☆ #2323 | Buy | $16.00→ $8.00-50.0% |
|
Aug 18
12:33 UTC
|
PBF
PBF Energy
|
◎ Target | Neil Mehta ★★★☆☆ #1715 | Neutral | $71.00→ $81.00+14.1% |
|
Aug 18
12:33 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Mara Goldstein not yet tracked | Outperform | $10.00→ $11.00+10.0% |
|
Aug 18
12:33 UTC
|
ELVN
Enliven Therapeutics
|
◎ Target | Salim Syed ★★★☆☆ #1456 | Outperform | $62.00→ $73.00+17.7% |
|
Aug 18
12:33 UTC
|
DUOT
Duos Technologies Group
|
◎ Target | Brett Knoblauch ★★★☆☆ #2101 | Overweight | $26.00→ $27.00+3.8% |
|
Aug 18
12:33 UTC
|
DK
Delek US
|
◎ Target | Neil Mehta ★★★☆☆ #1715 | Buy | $73.00→ $83.00+13.7% |
|
Aug 18
12:33 UTC
|
CLMT
Calumet
|
◎ Target | Neil Mehta ★★★☆☆ #1715 | Neutral | $40.00→ $45.00+12.5% |
|
Aug 18
12:33 UTC
|
CBLL
CeriBell
|
◎ Target | Marie Thibault ★★★☆☆ #1929 | Buy | $28.00→ $30.00+7.1% |
|
Aug 18
12:33 UTC
|
ARGX
argenex
|
◎ Target | David Nierengarten ★★★☆☆ #2074 | Outperform | $1,050.00→ $1,150.00+9.5% |
|
Aug 18
12:33 UTC
|
ARGX
argenex
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $932.00→ $1,200.00+28.8% |
|
Aug 18
12:33 UTC
|
ARGX
argenex
|
◎ Target | Douglas Tsao ★★★☆☆ #2247 | Buy | $940.00→ $1,202.00+27.9% |
|
Aug 18
12:33 UTC
|
AMGN
Amgen
|
◎ Target | Carter Gould ★★☆☆☆ #2325 | Neutral | $350.00→ $400.00+14.3% |
|
Aug 18
12:33 UTC
|
AMGN
Amgen
|
◎ Target | Salim Syed ★★★☆☆ #1456 | Neutral | $303.00→ $352.00+16.2% |
|
Aug 18
12:33 UTC
|
KRG
Kite Realty Group Trust
|
↓ Downgrade | Todd Thomas ★★★☆☆ #1029 | Overweight→ Sector Weight | |
|
Aug 18
12:33 UTC
|
COLD
Americold Realty Trust
|
↑ Upgrade | Samir Khanal ★★★☆☆ #1530 | Underperform→ Neutral | $15.00→ $16.00+6.7% |
|
Aug 18
12:33 UTC
|
CBLL
CeriBell
|
↑ Upgrade | firm only | Neutral | |
|
Aug 18
12:33 UTC
|
AKR
Acadia Realty Trust
|
↑ Upgrade | Todd M. Thomas not yet tracked | Sec→ r Weight ➝ Overweight | $25.00 |
|
Aug 18
11:33 UTC
|
EAAS
eEnergy Group
|
◎ Target | firm only | Buy | GBX 12→ GBX 9-25.0% |
|
Aug 18
11:33 UTC
|
BBWI
Bath & Body Works
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 18
10:33 UTC
|
VSVS
Vesuvius
|
◎ Target | firm only | Buy | GBX 520→ GBX 480-7.7% |
|
Aug 18
10:33 UTC
|
RR
Rolls-Royce Holdings plc
|
◎ Target | firm only | Buy | GBX 1,430→ GBX 1,900+32.9% |
|
Aug 18
10:33 UTC
|
GGP
Greatland Resources
|
◎ Target | firm only | Buy | GBX 816→ GBX 750-8.1% |
|
Aug 18
10:33 UTC
|
SCRYY
Scor
|
↓ Downgrade | firm only | Sell | |
|
Aug 18
10:33 UTC
|
OXB
Oxford Biomedica
|
↓ Downgrade | firm only | Hold | GBX 800→ GBX 595-25.6% |
|
Aug 18
09:33 UTC
|
SGRO
SEGRO
|
◎ Target | firm only | Buy | GBX 991→ GBX 995+0.4% |
|
Aug 18
09:33 UTC
|
BP
BP
|
◎ Target | firm only | Buy | GBX 600→ GBX 605+0.8% |
|
Aug 18
06:32 UTC
|
KRG
Kite Realty Group Trust
|
↓ Downgrade | firm only | Overweight→ Sector Weight | |
|
Aug 18
06:32 UTC
|
AKR
Acadia Realty Trust
|
↑ Upgrade | firm only | Sec→ r Weight ➝ Overweight | $25.00 |
|
Aug 18
00:32 UTC
|
ZS
Zscaler
|
◎ Target | Shaul Eyal ★★★☆☆ #1723 | Buy | $180.00→ $200.00+11.1% |
|
Aug 18
00:32 UTC
|
ZS
Zscaler
|
◎ Target | Richard Poland ★★☆☆☆ #2695 | Overweight | $180.00→ $210.00+16.7% |
|
Aug 18
00:32 UTC
|
YUM
Yum! Brands
|
◎ Target | John Staszak ★★★☆☆ #1383 | Buy | $185.00→ $180.00-2.7% |
|
Aug 18
00:32 UTC
|
YSWY
Yesway
|
◎ Target | John Heinbockel ★★★☆☆ #1810 | Buy | $30.00→ $32.00+6.7% |
|
Aug 18
00:32 UTC
|
XOM
ExxonMobil
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $182.00→ $177.00-2.7% |
|
Aug 18
00:32 UTC
|
VNOM
Viper Energy
|
◎ Target | Betty Jiang ★★☆☆☆ #2595 | Overweight | $60.00→ $58.00-3.3% |
|
Aug 18
00:32 UTC
|
VEEV
Veeva Systems
|
◎ Target | David Grossman ★★★☆☆ #1152 | Buy | $230.00→ $275.00+19.6% |
|
Aug 18
00:32 UTC
|
VEEV
Veeva Systems
|
◎ Target | Ken Wong not yet tracked | Outperform | $225.00→ $300.00+33.3% |
|
Aug 18
00:32 UTC
|
URG
Ur Energy
|
◎ Target | Andrew D. Wong not yet tracked | Outperform | $1.75→ $1.60-8.6% |
|
Aug 18
00:32 UTC
|
TRNO
Terreno Realty
|
◎ Target | Richard Anderson ★★★★★ #229 | Overweight | $75.00→ $77.00+2.7% |
|
Aug 18
00:32 UTC
|
TGT
Target
|
◎ Target | Michael Baker ★★★★☆ #895 | Buy | $155.00→ $170.00+9.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.